Visual Evoked Responses in Alzheimer's Disease: A Review

Clinical EEG and Neuroscience

Volumn 28, Issue 3, 1997, Pages 137-142

  Moore, Norman C ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's Disease; Magnocellular; Parvocellular; Visual Evoked Responses (VER)

Indexed keywords

ALZHEIMER DISEASE; ANTICHOLINERGIC EFFECT; BRAIN MAPPING; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST; EVOKED VISUAL RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; VISUAL CORTEX;

AGED; ALZHEIMER DISEASE; EVOKED POTENTIALS, VISUAL; HUMANS; PHOTIC STIMULATION; REACTION TIME; RETINA; VISUAL CORTEX; VISUAL PATHWAYS;

EID: 0030839982     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005949702800304     Document Type: Article

References (48)

1. Growdon JH. Advances in the diagnosis of Alzheimer's disease. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM,(eds). Recent Advances in Alzheimer's Disease and Related Disorders. New York: Wiley; 1995: 139-153.
2. Doggett CE Harding GFA Orwin A. Flash and pattern evoked potentials in patients with presenile dementia. Electroencephalogr Clin Neurophysiol 1981; 52: I00P Abstract.
3. Wright CE Harding GFA Orwin A. Presenile dementia: the use of the flash and pattern VEP in diagnosis. Electroencephalogr Clin Neurophysiol 1984; 57: 405-415.
4. Wright CE Harding GFA Orwin A. The flash and pattern VEP as a diagnostic indicator of dementia. Doc Ophthalmol 1986; 62: 89-96.
5. Katz B Rimmer S Iragui V Katzman R. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degneration? Ann Neurol 1989; 26: 221-225.
6. Ray PG Meador KJ Loring DW, et al. Effects of scopolamine on visual evoked potentials in aging and dementia. Electroencephalogr Clin Neurophysiol 1991; 80: 347-351.
7. Philpot MP Amin D Levy R. Visual evoked potentials in Alzheimer's disease: correlations with age and severity. Electroencephalogr Clin Neurophysiol 1990; 77: 323-329.
8. Moore NC Tucker KA Jann MW Hostetler RM Coburn KL. Flash P2 delay in primary degenerative dementia of the Alzheimer type. Prog Neuro-Psychopharmacol & Biol Psychiat 1995; 19: 403-410.
9. Cosi V Vitelli E Gozzoli L Corona A Ceroni M Callieco R. Visual evoked potentials in aging of the brain. In: Courjon J, Mauguiere F, Revol M,(eds). Clinical Applications of Evoked Potentials in Neurology. New York: Raven Press; 1982: 109-115.
10. Harding GFA Wright CE Orwin A. Primary presenile dementia: the use of the visual evoked potential as a diagnostic indicator. Br J Psychiatry 1985; 147: 532-539.
11. Wright CE Furlong PL. Visual evoked potentials in elderly patients with primary or multi-infarct dementia. Br J Psychiat 1988; 152: 679-682.
12. Aguglia U Gambarelli D Farnarier G Quattrone A. Different susceptibilities of the geniculate and extrageniculate visual pathways to human Creutzfeldt-Jakob disease (a combined neurophysiological-neuropathological study). Electroencephalogr Clin Neurophysiol 1991; 78: 413-423.
13. Coburn KL Ashford JW Moreno MA. Visual evoked potentials in dementia: selective delay of flash P2 in probable Alzheimer's disease. J Neuropsychiatry Clin Neurosciences 1991; 3: 431-435.
14. Brodie EE Allan D Brooks DN McCullough J Foulds WS. Flash and pattern reversal visual evoked responses in normal and demented elderly. Cortex 1992; 28: 289-293.
15. Swanwick GRJ Rowan M Coen RF, et al. Clinical application of electrophysiological markers in the differential diagnosis of depression and very mild Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 60: 82-86.
16. McKhann G Drachman D Folstein M Katzman R Price D Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-944.
17. Harding GFA Daniels R Panchal S Drasdo N Anderson SJ. Visual evoked potentials to flash and pattern reversal stimulation after administration of systemic or topical scopolamine. Doc Ophthalmol 1994; 86: 311-323.
18. Coben LA Danziger WL Hughes CP. Visual evoked potentials in mild senile dementia of Alzheimer type. Electroencephalogr Clin Neurophysiol 1983; 55: 121-130.
19. Pollock VE Schneider LS Chui HC Henderson V Zemansky M Sloane RB. Visual evoked potentials in dementia: a meta-analysis and empirical study of Alzheimer's disease patients. Biol Psychiatry 1989; 25: 1003-1013.
20. Sloan EP Fenton GW Kennedy NSJ MacLennan JM. Neurophysiology and SPECT cerebral blood flow patterns in dementia. Electroencephalogr Clin Neurophysiol 1994; 91: 163-170.
21. Grayson AS Weiler EM Sandman DE. Visual evoked potentials in early Alzheimer's dementia: an exploratory study. J Gen Psychol 1995; 122: 113-129.
22. Orwin A Wright CE Harding GFA Rowan DC Rolfe EB. Serial visual evoked potential recordings in Alzheimer's disease. Br Med J 1986; 293: 9-10.
23. Sloan EP Fenton GW. Serial visual evoked potential recordings in geriatric psychiatry. Electroencephalogr Clin Neurophysiol 1992; 84: 325-331.
24. Swanwick GRJ Rowan M Coen RF, et al. Longitudinal visual evoked potentials in Alzheimer's disease: a preliminary report. Biol Psychiatry 1996; 39: 455-457.
25. Moore NC Tucker KA Jann MW Hostetler RM Coburn KL. Flash P2 delay of primary degenerative dementia of the Alzheimer type increases with time. Brain Topography 1995; 7(4): 333. Abstract.
26. Tartaglione A Bandini F Maculotti M Marogna M Spadavecchia L Favale E. Eye closure affects flash VEP latency in dementia. Electroencephalogr Clin Neurophysiol 1995; 96: 197-205.
27. Partanen J Hartikainen P Kononen M Jousmaki V Soininen H Riekkinen P. Prolonged latencies of pattern reversal visual evoked early potentials in Alzheimer disease. Alzheimer Dis Assoc Disord 1994; 8: 250-258.
28. Livingstone M Hubel D. Segregation of form, color, movement, and depth: anatomy, physiology, and perception. Science 1988; 240: 740-749.
29. Blumhardt LD Halliday AM. Cortical abnormalities and the visual evoked response. In: Spekreijse H, Apkarian PA (eds). Visual Pathways: Electrophysiology and Pathology. Documenta Ophthalmologica Proceedings. The Hague: Junk, 1981; 27: 347-365.
30. Wright CE Drasdo N Harding GFA. Pathology of the optic nerve and visual association area. Information given by the flash and pattern visual evoked potential, and the temporal and spatial contrast sensitivity function. Brain 1987; 110: 107-120.
31. Daniels R Harding GFA Anderson SJ. Effect of dopamine and acetylcholine on the visual evoked potential. Internat J Psychophysiol 1994; 16: 251-261.
32. Armstrong RA Syed AB. Alzheimer's disease and the eye. Ophthal Physiol Opt 1996; 16: S2-S8.
33. Mendez MF Mendez MA Martin R Smyth KA Whitehouse PJ. Complex visual disturbances in Alzheimer's disease. Neurology 1990; 40: 439-443.
34. Cronin-Golomb A Rizzo JF Corkin S Growdon JH. Visual function in Alzheimer's disease and normal aging. Ann NY Acad Sci 1991; 640: 28-35.
35. Rizzo JF Cronin-Golomb A Growdon JH, et al. Retinocalcarine function in Alzheimer's disease. Arch Neurol 1992; 49: 93-101.
36. Ducati A Fava E Motti EDF. Neuronal generators of the visual evoked potentials: intracerebral recording in awake humans. Electroencephalogr Clin Neurophysiol 1988; 71: 89-99.
37. Armstrong RA. Neuropathological differences between areas B17 and B18: implications for visual evoked responses in Alzheimer's disease. Dementia 1994; 5: 247-251.
38. Haimovic IC Pedley TA. Hemifield pattern reversal visual evoked potentials. II. Lesions of the chiasm and posterior visual pathways. Electroencephalogr Clin Neurophysiol 1982; 54: 121-131.
39. Lewis DA Campbell MJ Terry RD Morrison JH. Laminar and regional distrubtions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci 1987; 7: 1799-1808.
40. Mielke R Kessler J Fink G Herholz K Heiss W-D. Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease. Int J Neurosci 1995; 82: 1-9.
41. Micheli E de Pietrini P Grady CL, et al. Alzheimer's disease with prominent visual impairment: a longitudinal PET study of cerebral glucose metabolism. Neurobiol Aging 1992; 13, 14.
42. Trobe JD. Visual distress in patients with Alzheimer's disease. In: Smith JL,(ed). Neuroophthalmology Enters the Nineties. Miami: Dutton Press; 1990: 227-283.
43. Kiyosawa M Bosley TM Chawluk J, et al. Alzheimer's disease with prominent visual symptoms: clinical and metabolic evaluation. Ophthalomology 1989; 96: 1077-1085.
44. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci 1990; 13: 296-302.
45. Parnavelas JG McDonald JK, The cerebral cortex. In: Emson PC,(ed). Chemical Neuroanatomy. New York: Raven Press; 1983; 505-549.
46. Fitzpatrick D Raczkowski D. The localization of neurotransmitters in the geniculostriate pathway. In: Dreher B, Robinson SR,(eds). Neuroanatomy of the Visual Pathways and Their Development. Boca Raton: CRC Press; 1991; 278-301.
47. Bajalan AAA Wright CE Van der Vliet VJ. Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrombromide: comparison with results in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1986; 49: 175-182.
48. Sannita WG Balestra V Di Bon G Rosadini G Marotta V. Human flash-VEP and quantitative EEG are independently affected by acute scopolamine. Electroencephalogr Clin Neurophysiol 1993; 86: 275-282.